Dogwood Therapeutics, Inc. (DWTX) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$27.97M | -128.7% |
| 2024 | -$12.23M | -124.5% |
| 2023 | -$5.45M | +55.8% |
| 2022 | -$12.32M | +21.3% |
| 2021 | -$15.64M | -56.3% |
| 2020 | -$10.01M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$27.97M | -128.7% |
| 2024 | -$12.23M | -124.5% |
| 2023 | -$5.45M | +55.8% |
| 2022 | -$12.32M | +21.3% |
| 2021 | -$15.64M | -56.3% |
| 2020 | -$10.01M | — |